From: Clinical characteristics and risk factors of mirror syndrome: a retrospective case-control study
Clinical Profiles | Non-mirror group (n = 23) | Mirror group (n = 14) | P value |
---|---|---|---|
Fetal features | |||
Time of fetal hydrops onset (wks) | 23.0 (9.4) | 27.8 (4.7) | 0.003 |
Placental thickening | 8/23 (34.8%) | 12/14 (85.7%) | 0.006 |
Polyhydramnios | 4/23 (17.4%) | 6/14 (42.9%) | 0.132 |
Maternal features | |||
Maternal age (years) | 28.0 (5.0) | 28.5 (9.0) | 0.699 |
Primipara | 11/23 (47.8%) | 4/14 (28.6%) | 0.314 |
Body weight gain | 5.5 (6.0) | 9.0 (8.0) | 0.003 |
Hypertension | 0/23 (0) | 5/14 (35.7%) | 0.005 |
Systolic Blood Pressure (mmHg) | 115 (12) | 131 (24) | < 0.001 |
Diastolic Blood Pressure (mmHg) | 64 (15) | 82 (13) | < 0.001 |
Anemia | 15/23 (65.2%) | 14/14 (100%) | 0.015 |
Hemoglobin (g/L) | 105 (31) | 88 (31) | < 0.001 |
Hematocrit (%) | 31.8 (3.6) | 26.4 (7.1) | < 0.001 |
Platelet counts (×109/L) | 237 (91) | 155 (122) | 0.005 |
Serum albumin (g/L) | 35.0 (3.2) | 25.8 (4.1) | < 0.001 |
Uric Acid (μmol/L) | 290 (32) | 546 (324) | 0.042 |
Creatinine (μmol/L) | 44 (8) | 59 (44) | 0.002 |
Proteinuria | 1/23 (4.3%) | 9/14 (64.3%) | < 0.001 |
Outcomes | |||
Termination of pregnancy | 23/23 (100%) | 12/14 (85.7%) | – |
Gestational age at delivery (wks) | 25.4 (8.9) | 29.1 (5.9) | 0.034 |
Cesarean section | 0/23 (0) | 7/14 (50%) | < 0.001 |
Placental edema | 15/23 (65.2%) | 14/14 (100%) | 0.015 |
Maternal morbidity | 2/23 (8.7%) | 12/14 (85.7%) | < 0.001 |
Postpartum hemorrhage | 1/23 (4.3%) | 7/14 (50%) | 0.002 |
Placenta accreta | 2/23 (8.7%) | 5/14 (35.7%) | 0.08 |
Other complications | 0/23 (0) | 10/14 (71.4%) | < 0.001 |
Blood products transfusion | 1/23 (4.3%) | 9/14 (64.3%) | < 0.001 |
Intensive care unit admission | 0/23 (0) | 6/14 (42.9%) | 0.001 |
Length of hospital stay (days) | 5 (3) | 11 (5) | < 0.001 |
Cost (dollars) | 582 (483) | 3597 (4023) | < 0.001 |